Literature DB >> 22451755

Neonatal rectal colonization with Malassezia furfur.

G J Gross1, N E Macdonald, A M Mackenzie.   

Abstract

Malassezia furfur and Candida albicans are fungal pathogens which have been recognized with increasing frequency as agents of mortality and serious morbidity in neonatal intensive care unit patients. A longitudinal study of oral, rectal and umbilical colonization by these organisms of newborns admitted to a neonatal intensive care unit within 24 h of birth was undertaken. Of 71 infants followed for a minimum of 10 days, 24 were colonized with M furfur and 12 with C albicans during the first 10 days of life. The lower gastrointestinal tract was found to be the most common colonization site for both organisms. Statistically significant (P<0.05) inverse associations were demonstrated between gestational age and risk of colonization with either organism at any site, and between birthweight or gestational age and risk of rectal colonization with either organism. Antibiotics were associated with a relative risk colonization of 4.06 (P=0.06) with either organism at any site. It is concluded that M furfur and C albicans are common colonizing organisms in a neonatal intensive care unit setting and are most frequently harboured in the lower gastrointestinal tract. M furfur, recently implicated as a systemic pathogen in this population, has not been previously recognized as a gastrointestinal commensal organism. The relationship between colonization and invasive fungal disease, and potential roles for preventive strategies, remain to be elucidated.

Entities:  

Keywords:  Malassezia furfur; Neonates

Year:  1992        PMID: 22451755      PMCID: PMC3307420          DOI: 10.1155/1992/895836

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  19 in total

1.  Enteric candidiasis. Diagnosis and clinical considerations.

Authors:  P J KOZINN; C L TASCHDJIAN
Journal:  Pediatrics       Date:  1962-07       Impact factor: 7.124

2.  Amphotericin B as a single agent in the treatment of systemic candidiasis in neonates.

Authors:  K M Butler; M A Rench; C J Baker
Journal:  Pediatr Infect Dis J       Date:  1990-01       Impact factor: 2.129

3.  [Orally administered nystatin to newborn infants in the prevention of candidiasis].

Authors:  R Blaschke-Hellmessen; R Schwarze; H Schmeiser; I Weigl
Journal:  Z Gesamte Hyg       Date:  1976-07

4.  Malassezia furfur skin colonization in infancy.

Authors:  L M Bell; G Alpert; P H Slight; J M Campos
Journal:  Infect Control Hosp Epidemiol       Date:  1988-04       Impact factor: 3.254

5.  Yeast colonization in hospitalized and nonhospitalized children.

Authors:  M I Marks; S Marks; M Brazeau
Journal:  J Pediatr       Date:  1975-10       Impact factor: 4.406

6.  Malassezia furfur skin colonization of infants hospitalized in intensive care units.

Authors:  D A Powell; J Hayes; D E Durrell; M Miller; M J Marcon
Journal:  J Pediatr       Date:  1987-08       Impact factor: 4.406

7.  Percutaneous central venous catheter colonization with Malassezia furfur: incidence and clinical significance.

Authors:  J L Aschner; A Punsalang; W M Maniscalco; M A Menegus
Journal:  Pediatrics       Date:  1987-10       Impact factor: 7.124

8.  Prophylactic oral nystatin and fungal infections in very-low-birthweight infants.

Authors:  M E Sims; Y Yoo; H You; C Salminen; F J Walther
Journal:  Am J Perinatol       Date:  1988-01       Impact factor: 1.862

9.  Broviac catheter-related Malassezia furfur sepsis in five infants receiving intravenous fat emulsions.

Authors:  D A Powell; J Aungst; S Snedden; N Hansen; M Brady
Journal:  J Pediatr       Date:  1984-12       Impact factor: 4.406

Review 10.  Malassezia fungemia in neonates and adults: complication of hyperalimentation.

Authors:  W M Dankner; S A Spector; J Fierer; C E Davis
Journal:  Rev Infect Dis       Date:  1987 Jul-Aug
View more
  1 in total

1.  Oral nystatin prophylaxis to prevent systemic fungal infection in very low birth weight preterm infants: a randomized controlled trial.

Authors:  Lily Rundjan; Retno Wahyuningsih; Chrissela Anindita Oeswadi; Miske Marsogi; Ayu Purnamasari
Journal:  BMC Pediatr       Date:  2020-04-17       Impact factor: 2.125

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.